- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | What's Going On With Bluejay Diagnostics Shares On Wednesday? | 3 | Benzinga.com | ||
| Di | Bluejay Diagnostics raises $8.5M in private placement | 2 | Investing.com | ||
| Di | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules | 4 | GlobeNewswire (USA) | ||
| Di | Why Is Bluejay Diagnostics Stock Soaring Tuesday? | 7 | Benzinga.com | ||
| BLUEJAY DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| Di | Morning Market Movers: Bluejay Diagnostics, Decent Holding, Abits Group, Sunshine Biopharma See Big Swings | 336 | AFX News | WASHINGTON (dpa-AFX) - At 7:35 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| Di | Bluejay Diagnostics partners with Argonaut for US manufacturing | 4 | Investing.com | ||
| Di | Bluejay Diagnostics, Inc.: Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership | 135 | GlobeNewswire (Europe) | ACTON, Mass. and CARLSBAD, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. ("Bluejay" or the "Company") (NASDAQ: BJDX), a medical diagnostics company focused on near-patient testing... ► Artikel lesen | |
| Di | Bluejay Diagnostics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 07.05. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Provides First Quarter 2026 Corporate Update | 111 | GlobeNewswire (Europe) | ACTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. ("Bluejay" or the "Company"), a medical diagnostics company focused on improving patient outcomes in critical care settings... ► Artikel lesen | |
| 07.05. | Bluejay Diagnostics, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 07.04. | Bluejay Diagnostics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 07.04. | Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial | 222 | GlobeNewswire (Europe) | ACTON, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. ("Bluejay" or the "Company"), a medical diagnostics company focused on rapid, near-patient testing, today announced the successful... ► Artikel lesen | |
| 16.03. | Bluejay Diagnostics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 12.03. | Bluejay Diagnostics, Inc.: Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting | 3 | GlobeNewswire (USA) | ||
| 06.03. | Bluejay Diagnostics, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 06.03. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.03. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook | 201 | GlobeNewswire (Europe) | ACTON, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" or the "Company"), a medical diagnostics company developing rapid near-patient tests to improve... ► Artikel lesen | |
| 20.02. | Bluejay Diagnostics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 20.02. | Bluejay Diagnostics meldet vollständige Ausübung vorausfinanzierter Optionsscheine | 1 | Investing.com Deutsch | ||
| 20.02. | Bluejay Diagnostics completes prefunded warrant exercises | 2 | Investing.com |
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 26,640 | +1,52 % | EQS-DD: Carl Zeiss Meditec AG: Peter Kameritsch, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
28.05.2026 / 14:57... ► Artikel lesen | |
| HIMS & HERS HEALTH | 24,200 | +1,94 % | Telemedizin-Aktie legt zu: 1,15-Milliarden-Deal: Hims & Hers expandiert radikal | © Foto: picture alliance / ZUMAPRESS.com | Avishek DasHims & Hers kauft sich mit Eucalyptus in neue Märkte ein - der Milliarden-Deal schürt Fantasie für den nächsten Wachstumsschub.Hims & Hers Health... ► Artikel lesen | |
| GE HEALTHCARE TECHNOLOGIES | 54,68 | +2,22 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,410 | +8,25 % | Jim Cramer on Clover Health: "You're in Pure Spec Mode There" | ||
| PICARD MEDICAL | 0,320 | 0,00 % | PICARD MEDICAL, INC. Issues Letter to Shareholders | TUCSON, Ariz., May 29, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 57,38 | -3,30 % | BrightSpring stockholders price 15M share offering at $58.75 | ||
| FRESENIUS | 36,670 | +1,97 % | Während Merck, Amgen, Novo Nordisk und Fresenius Milliarden bewegen, wächst die Fantasie im Zelltherapie-Sektor | ||
| SIEMENS HEALTHINEERS | 34,650 | +3,43 % | Mentice AB: Mentice and Siemens Healthineers Announce Co-Marketing Partnership to Advance Neurovascular Treatment Planning | Gothenburg, Sweden - June 2026 - Mentice AB, a global leader in simulation and clinical decision support solutions for Image-Guided Therapies, today announced a co-marketing agreement with Siemens Healthineers... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,740 | +4,78 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung gemäß Artikel 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014 und Artikel 2 Abs. 1 der Delegierten... ► Artikel lesen | |
| VERU | 4,220 | 0,00 % | VERU INC. - 8-K, Current Report | ||
| BILLIONTOONE | 104,49 | +6,23 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| GENEDX | 56,25 | 0,00 % | Sema4.ai's autonomous agent building platform gets simpler to use, adds deeper business context and more | ||
| ALIGNMENT HEALTHCARE | 15,065 | +10,45 % | Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year | ||
| UNITEDHEALTH | 341,60 | +5,11 % | Aktien New York Ausblick: Techwerte unter Druck nach KI-Ausblick von Broadcom | NEW YORK (dpa-AFX) - Ein enttäuschender Ausblick des Chipkonzerns Broadcom dürfte am Donnerstag für Moll-Stimmung an der Technologiebörse Nasdaq sorgen. Der Broker IG taxierte den viel beachteten Branchenindex... ► Artikel lesen | |
| HEARTFLOW | 28,790 | 0,00 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen |
BLUEJAY DIAGNOSTICS INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 5,660 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BLUEJAY DIAGNOSTICS INC finden Sie auf Wallstreet Online.